SteraMist is effective against a wide range of common and uncommon microbes, including all influenzas (including H1N1 and H5N2 Avian Flu), bacteria such as Escherichia coli, MRSA, and Pseudomonas ...
Although ABW agents will not replace threats posed by traditional biological agents such as Bacillus anthracis (anthrax) and Variola (smallpox), they will necessitate novel approaches to ...
Hosted on MSN15d
The Soviet Anthrax Bio Weapon Incident 1979It is an invisible spore fog of Bacillus Anthracis, a dangerous bacteria that causes one of the deadliest diseases there is; Anthrax. We reveal the world's darkest and greatest disasters all based ...
Inc. (NYSE: EBS) today announced the exercise of contract option and modification valued at approximately $20 million to supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense ...
Emergent BioSolutions Inc. (NYSE: EBS) has secured a $50 million contract option from the Biomedical Advanced Research and ...
StockNews.com upgraded shares of Emergent BioSolutions (NYSE:EBS – Free Report) from a hold rating to a buy rating in a report released on Tuesday morning. EBS has been the topic of several other ...
HC Wainwright reiterated their buy rating on shares of Emergent BioSolutions (NYSE:EBS – Free Report) in a research note issued to investors on Friday morning,Benzinga reports. They currently have a ...
Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection: Staten Island, New York Tuesday, January 7, 2025, 18:00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback